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isteria monocytogenes
 
 is a facultative intracellular
bacterial pathogen that escapes from a phagosome
and grows in the host cell cytosol. The pore-forming
cholesterol-dependent cytolysin, listeriolysin O (LLO),
mediates bacterial escape from vesicles and is 
 

 
10-fold
more active at an acidic than neutral pH. By swapping
dissimilar residues from a pH-insensitive orthologue,
perfringolysin O (PFO), we identified leucine 461 as
unique to pathogenic 
 
Listeria
 
 and responsible for the acidic
pH optimum of LLO. Conversion of leucine 461 to the
threonine present in PFO increased the hemolytic activity
of LLO almost 10-fold at a neutral pH. 
 
L. monocytogenes
L
 
synthesizing LLO L461T, expressed from its endogenous
site on the bacterial chromosome, resulted in a 100-fold
virulence defect in the mouse listeriosis model. These
bacteria escaped from acidic phagosomes and initially grew
normally in cells and spread cell to cell, but prematurely
permeabilized the host membrane and killed the cell.
These data show that the acidic pH optimum of LLO results
from an adaptive mutation that acts to limit cytolytic activity
to acidic vesicles and prevent damage in the host cytosol,
a strategy also used by host cells to compartmentalize
lysosomal hydrolases.
 
Introduction
 
A common strategy among microbial pathogens is exploitation
of the normal host process of endosomal/phagosomal
acidification. For example, many enveloped viruses require
acidification to trigger fusion of the viral envelope with
an endosomal membrane (Hernandez et al., 1996). Similarly,
many bacterial AB-toxins require acidification of the endosome
to stimulate pore formation by the B-subunit and subsequent
translocation of the enzymatic A-subunit into the host cytosol
(Falnes and Sandvig, 2000). Lastly, some intracellular
pathogens such as 
 
Trypanosoma cruzi
 
 and 
 
Listeria monocytogenes
 
use acid-activatable pore-forming proteins to mediate escape
from a phagosome into the host cell cytosol (Geoffroy et al.,
1987; Tilney and Portnoy, 1989; Ley et al., 1990).
The capacity of 
 
L. monocytogenes
 
 to escape from an acidic
phagosomal compartment is largely mediated by listeriolysin
O (LLO),* an essential determinant of 
 
L. monocytogenes
 
pathogenesis (Portnoy et al., 1992a). LLO is a member of a
family of cholesterol-dependent cytolysins (CDCs) secreted
by a large number of pathogenic gram-positive bacteria
(Bayley, 1997). Other examples include streptolysin O,
perfringolysin O (PFO), and pneumolysin. LLO is the only
CDC that is made by an intracellular pathogen and has a
pronounced acidic pH optimum. Although replacement of
LLO with PFO complements for secreted cytolytic activity,
it does not restore virulence (Jones and Portnoy, 1994a). 
 
L.
monocytogenes
 
 secreting PFO are somewhat defective in
escaping from a vacuole, but, strikingly, kill the host cell
subsequent to entry into the cytosol. The cytotoxicity of
PFO is due in part to the lack of a PEST-like sequence in PFO,
which targets LLO for phosphorylation and/or degradation in
the cytosol (Decatur and Portnoy, 2000). However, bacteria
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synthesizing PFO containing the PEST-like sequence are
only partially restored in virulence. Unlike LLO, PFO does
not have a pronounced acidic pH optimum, but rather is ac-
tive at both acidic and neutral pHs (Portnoy et al., 1992b).
We hypothesized that the acidic pH optimum of LLO is im-
portant for either efficient lysis of the phagosome and/or
lack of toxicity in the cytosol.
The crystal structure of a soluble monomeric form of PFO
has revealed a four domain protein with its COOH-terminal
domain 4 mediating binding to cholesterol-rich membranes
(Rossjohn et al., 1997). Subsequent to membrane binding,
PFO oligomerizes into a large complex, containing up to 50
individual monomers, that forms large pores in the target
membrane (Shepard et al., 2000). The structure of LLO
awaits solution, but based on the overall similarity in se-
quence and function to PFO, it is reasonable to assume con-
servation in the relation of sequences to functions. However,
because it has no direct correlate, the biochemical basis of
LLO’s acidic pH optimum cannot be inferred from the
structure of PFO. Further, the role of LLO’s acidic pH opti-
mum in pathogenesis is not known. In this study, we identi-
fied a single residue in LLO that increased its activity at a
neutral pH, making its activity profile similar to that of
PFO. We then evaluated how this mutation affected 
 
L.
monocytogenes
 
 pathogenesis.
 
Results
 
Identification of amino acid residues within LLO that 
confer an acidic pH optimum
 
We sought to isolate a mutation in LLO that increased its
activity at a neutral pH and thus caused LLO to act like
PFO. We began with the assumption that PFO contains a
sequence that facilitates its activity over a broad pH range,
and placing this sequence in LLO would alter LLO’s pH
profile. Because domain 4 of PFO was implicated in mem-
brane binding and insertion (Nakamura et al., 1995), it was
deemed a good candidate for regulating pH-dependent cy-
tolysis. A chimeric protein consisting of the first three do-
mains of LLO and the fourth domain of PFO was gener-
ated. The domain 4 chimera, LLO, and PFO were expressed
as COOH-terminally his–tagged recombinant proteins in
 
Escherichia coli
 
 and purified for analysis of hemolytic activ-
ity. The domain 4 chimera was less active than either PFO
or LLO, yet its activity at both pH 5.5 and 7.4 was similar
(Fig. 1 C). We interpreted these results to indicate that
within the fourth domain of LLO were sequences that con-
trol the pH activity profile.
Next, we divided the fourth domain of LLO into 12 sub-
domains, each containing amino acids dissimilar to those of
PFO, and swapped those regions of dissimilarity from PFO
into LLO (Fig. 1 A). Two chimeras (5 and 10) showed a dra-
matic reduction in the ratio of activity at an acidic pH to that
at a neutral pH (Fig. 1 B). However, chimera 10 was 
 

 
10-
fold less active than LLO (unpublished data) and was not
studied further. The four amino acid changes in chimera 5
were then individually introduced into LLO. A single amino
acid change, L461T, increased the hemolytic activity of LLO
nearly 10-fold at a neutral pH without decreasing specific ac-
tivity at pH 5.5. Thus, a single amino acid substitution is
sufficient to confer the pH activity profile of PFO onto LLO
(Fig. 1 C). Additionally, L461 is unique to the CDC of the
pathogenic species of the 
 
Listeria
 
 genus (Fig. 1 D).
 
The L461T mutation in LLO reduces virulence
 
Having established that the L461T mutation conferred
greater activity on purified LLO at a neutral pH, we intro-
duced the mutation onto the chromosome of 
 
L. monocytoge-
nes
 
 by allelic exchange. The resulting strain, DP-L4017, was
used for further studies. The mutation had no effect on bac-
terial growth in vitro (unpublished data). Supernatant fluid
derived from cultures of LLO L461T bacteria had a quantity
of LLO similar to the wild type and had hemolytic activities
at pH 5.5 and 7.4 similar to those of the purified proteins
from 
 
E. coli
 
 (unpublished data).
The capacity of the LLO L461T mutant to grow in ani-
mals was evaluated by the lethal dose-50 (LD
 
50
 
) in the
mouse listeriosis model. In BALB/c mice, the LD
 
50
 
 of the
LLO L461T mutant was 
 

 
3 
 

 
 10
 
6
 
 as compared with an
Figure 1. Identification of amino acid residues that control the 
pH dependence of LLO hemolytic activity. (A) Alignment of domain 
4 of LLO and PFO. Amino acid sequences from PFO (bottom of the 
gray boxes) were exchanged with the amino acids within LLO (top 
of the gray boxes). Each chimera is numbered from 1 to 12 at the 
bottom of the gray boxes. The star indicates the L461T mutation. (B) 
Analysis of the hemolytic activity of the 12 chimeric proteins,
expressed in E. coli, represented as the ratio of the activities at pH 
5.5 and 7.4. (C) Hemolytic units at pH 5.5 and 7.4 of 40 ng of 
purified histidine-tagged wild-type LLO, PFO, the domain 4 chimera, 
and the L461T LLO mutant. Error bars represent the standard
deviation. (D) Alignment of 10 CDCs in the 461 region. Star and the 
gray box indicate position 461 in LLO. Empty boxes indicate identity. 
The listed toxins are from the following organisms: listeriolysin, L. 
monocytogenes; perfringolysin, C. perfringens; ivanolysin, L. 
ivanovi; seeligeriolysin, L. seeligeri; streptolysin, Streptococcus 
pyogenes; pneumolysin, S. pneumoniae, cereolysin, Bacillus 
cereus; alveolysin, Paenibacillus alvei; suilysin, S. suis; pyolysin, 
Arcanobacterium pyogenes.
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LD
 
50
 
 of 1–3 
 

 
 10
 
4
 
 for wild-type bacteria (Table I). These
data suggest that LLO pH dependence contributes to the in
vivo growth of 
 
L. monocytogenes.
 
The LLO L461T mutation does not affect the efficiency 
or pH of phagosomal escape
 
Based on the observation that LLO has an acidic pH opti-
mum and the bacteria escape from phagosomes at an acidic
pH (Beauregard et al., 1997), we hypothesized that a mu-
tant LLO with greater activity at a neutral pH may act pre-
maturely and not mediate escape efficiently. We used a fluo-
rescence-based assay to monitor escape from the phagosome
based on the observation that bacteria within the cytosol nu-
cleate host actin filaments on their surface, whereas bacteria
in vacuoles do not. We found that the LLO L461T mutant
escaped from the phagosome of bone marrow–derived mac-
rophages (BM
 

 
) similarly to wild-type bacteria, 72 
 

 
 2%
versus 76 
 

 
 2%, respectively, after 2 h (Table I).
Previous studies have indicated that preventing acidifica-
tion of the phagosome with the vacuolar proton ATPase in-
hibitor bafilomycin A1 limits 
 
L. monocytogenes
 
 escape to the
cytosol (Conte et al., 1996; Beauregard et al., 1997). We
reasoned that escape of the LLO L461T mutant might not
be affected by bafilomycin A1 treatment because its cyto-
lysin was active at a neutral pH. However, when bafilomycin
A1 was added to the macrophages, both the mutant and the
wild-type bacteria escaped less efficiently (Table I). When
bafilomycin A1 was present throughout the assay, both
strains escaped with about a third of the efficiency of un-
treated controls.
Because treatment with bafilomycin A1 prevented escape
of the LLO L461T mutant as well as the wild-type bacteria,
it would appear that the additional activity of the mutant at
a neutral pH does not eliminate the requirement for phago-
some acidification. Therefore, we measured the pH of bacte-
rium-containing phagosomes using a pH-sensitive fluid-
phase fluorescent dye to determine if the LLO L461T
mutant altered the phagosomal maturation process. We
found that phagosomes containing the LLO L461T mutant
reached an average minimum pH of 5.5 
 

 
 0.3 before perfo-
ration, similar to that of the wild type, which reached a min-
imum mean pH of 5.7 
 
 
 
0.2 (Table I). We concluded that
the LLO L461T mutation had no effect on phagosomal
acidification or escape, and that phagosomal acidification
was necessary for the escape of the LLO L461T mutant as
well as for wild type. Therefore, it is unlikely that the LLO
L461T mutant’s virulence defect reflects a reduced ability to
escape from phagosomes or an effect on phagosome matura-
tion. The defect is likely due to the alteration of a different
part of the pathogenic life cycle.
 
L. monocytogenes
 
 LLO L461T damages host
cell membranes
 
Because the LLO L461T mutant had no defect in phagoso-
mal escape, we next examined the capacity of the bacteria to
grow in host cells using a quantitative tissue culture assay
(Portnoy et al., 1988). In this assay, adding the antibiotic
gentamicin to the culture medium kills extracellular bacteria
but has no measurable effect on the growth of intracellular
wild-type bacteria. Between 2 and 5 h after infection, the
LLO L461T mutant grew well within J774 macrophages
with an average apparent doubling time of 58 
 
 
 
8 min,
slightly longer than the wild-type doubling time of 42 
 

 
 4
min (Fig. 2 A). Strikingly, between 5 and 8 h after infection,
the LLO L461T mutant grew with a nearly twofold longer
average apparent doubling time (159 
 

 
 30 min compared
with the wild-type doubling time of 83 
 
 
 
8 min). Addition-
ally, the LLO L461T mutant did not grow to as high a max-
imum number of bacteria.
We reasoned that the LLO L461T mutant’s longer appar-
ent doubling times and lower maximum bacterial numbers
could reflect either a decrease in the overall growth rate or,
more likely, an increase in the death of a subpopulation of
intracellular bacteria. The analysis is complicated by the fact
that after 5 h, 
 
L. monocytogenes
 
 spread from cell to cell (Sun
et al., 1990; Gedde et al., 2000). To eliminate cell-to-cell
spread from the analysis, an in-frame deletion was intro-
duced within the 
 
actA
 
 gene. The resulting strain was fully ca-
pable of vacuolar escape and intracellular growth within the
original host cell, but was unable to nucleate actin filaments
and thus unable to enter the secondary cell’s double-mem-
braned vesicle or spread from cell to cell (unpublished data).
As previously observed (Brundage et al., 1993), a 
 

 
ActA
strain expressing wild-type LLO grew intracellularly for the
first 8 h, after which bacterial numbers rapidly dropped due
to death of the host cell and influx of gentamicin (Fig. 2 B).
A corresponding drop in the number of LLO L461T 
 

 
ActA
bacteria was observed, but the drop occurred at 5 h instead of
at 8 h observed for the wild type. Treatment with the phar-
macological inhibitor of actin polymerization, cytochalasin
D, which prevents bacterial intracellular motility, led to sim-
ilar growth defects as the deletion of ActA (unpublished
data). Thus, the growth defect of LLO L461T bacteria was
more pronounced when cell-to-cell spread was inhibited. (As
shown in the next section, the LLO L461T mutant is not de-
fective in the ability to spread from cell to cell.)
 
Table I. 
 
L. monocytogenes
 
 lethal dose-50 and phagosomal escape measurements
Strain Lethal dose-50 Percent phagosomal escape
 
c
 
Average pH
 
c,d
 
 at perforation
No treatment 0.5 
 

 
M bafilomycin A1
 
Wild type (10403S) 1–3 
 

 
 10
 
4b
 
72 
 

 
 2 23 
 

 
 6 5.7 
 
 
 
0.3
LLO-minus
 
a
 
1 
 
 
 
10
 
9
 
0 0 ND
LLO L461T
 

 
3 
 

 
10
 
6
 
76 
 
 
 
2 25 
 
 
 
8 5.5 
 
 
 
0.2
 
a
 
The LLO-minus strain (2161) was published in Jones and Portnoy (1994a).
 
b
 
LD
 
50
 
 for 10403S was published in Portnoy et al. (1988).
 
c
 
Error indicates standard deviation.
 
d
 
Average represents 11 perforated phagosomes measured for wild type and 17 for LLO L461T.
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For both wild-type and LLO L461T bacteria, the drop
in colony-forming units was only observed when gentami-
cin was present in the assay medium (unpublished data).
When host membranes become permeabilized during a cell
culture infection, gentamicin present in the culture me-
dium enters the host cell and kills intracellular bacteria
(Brundage et al., 1993; Decatur and Portnoy, 2000).
Therefore, the gentamicin-dependent drop in numbers of
intracellular bacteria suggested that host membranes had
been permeabilized. Because the LLO L461T 
 

 
ActA mu-
tant died earlier than the wild-type LLO 
 

 
ActA strain, and
because this occurred in a gentamicin-dependent manner,
we hypothesized that the greater activity of LLO L461T at
a neutral pH led to earlier permeabilization of the host cell
membrane. If this hypothesis were true, damage could be
monitored by detecting release of the host cell enzyme lac-
tate dehydrogenase (LDH) from the cytosol of the J774
cells into the culture medium. During a 7 h infection with
wild-type bacteria, very little LDH was released either in
the presence or absence of gentamicin (Fig. 2 C). In the
absence of gentamicin, both the LLO L461T– and LLO
L461T 
 

 
ActA–infected cells released nearly 100% of their
LDH, indicating a major disruption of the host plasma
membrane. Interestingly, when J774 cells were incubated
in the constant presence of gentamicin, very little LDH
was released during infection by any strain. Presumably,
permeabilization of the cell allowed the influx of gentami-
cin, which then killed the intracellular bacteria (Fig. 2 B)
and prevented further permeabilization and LDH release.
When gentamicin was removed after 2 h, only the J774
cells infected with the LLO L461T 
 

 
ActA mutant released
high quantities of LDH. When a monoclonal antibody
that neutralizes LLO activity (Edelson and Unanue, 2001)
was added extracellularly to the J774 cells, there was no ef-
fect on LDH release, indicating that toxicity is mediated
by intracellular LLO (unpublished data).
A more sensitive method to test the integrity of the plasma
membrane uses the membrane-impermeant dye propidium
iodide. When membrane integrity is compromised, the dye
enters the cell and increases its fluorescence upon binding
cellular DNA. Staining can be measured by flow cytometry.
After infection with the wild-type bacteria, most macro-
phage host cells still excluded the dye (Fig. 3 B). In contrast,
infection with the LLO L461T mutant led to permeabiliza-
Figure 2. Growth of bacteria within J774 cells and release of 
LDH by infected cells. (A and B) Growth of bacteria within the J774 
macrophage-like cell line in the presence of 50 mg/ml gentamicin. 
Gentamicin kills extracellular bacteria. Colony-forming units at 
each time point represent the average  SD of results from three 
coverslips. (C) LDH release into tissue culture medium was used to 
monitor perforation of the host cell plasma membrane. Release of 
LDH after infection of J774 cells by each strain was compared with 
total LDH determined after lysis with detergent. LDH release was 
determined for different exposures of the cultures to gentamicin, 
which kills intracellular bacteria when host cells have been 
permeabilized. Error bars represent the SD of three infections.
Figure 3. Assessment of host plasma membrane integrity using 
flow cytometry. (A–F) CD-1 murine BMs were stained with 2 g/
ml propidium iodide 7 h after infection with the indicated strains. The 
gray shaded histogram represents uninfected cells. The fluorescence 
range of cells scored as permeabilized, indicated by the marker M1, 
was defined by adding 106 hemolytic units of purified histidine-tagged 
LLO L461T to the macrophages. A total of 2.5  104 cells were 
scored in each assay; half are displayed in the histograms. The 
percentage of cells falling within the fluorescence range of marker 
M1 relative to the total number of cells counted is shown.
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tion of about half of the macrophages (Fig. 3 C), and infec-
tion with the LLO L461T 
 

 
ActA mutant permeabilized
most of the macrophages (Fig. 3 E).
To address the possibility that the LLO L461T molecule
had altered cytosolic stability, which could lead to increased
cytotoxicity, we infected J774 cells and examined the steady-
state quantity of cytosolic LLO. We found that there was
approximately twofold more cytosolic LLO L461T than
wild type (Fig. 4). However, when J774 cells were infected
with a strain harboring two copies of the gene encoding
LLO, so that they produce twice as many hemolytic units, a
similar quantity of LLO to the LLO L461T mutant was ob-
served (Fig. 4). However, despite the fact that infection with
the merodiploid led to a concentration of LLO in the cyto-
sol similar to the mutant, the merodiploid damaged the host
cell’s plasma membrane no more than the wild-type bacteria
(Fig. 3 F). Together, these data suggested that the decreased
growth of the LLO L461T mutant was associated with per-
meabilization of the host cells due to increased activity of the
LLO L461T at a neutral pH, and was not due to an in-
creased cytosolic concentration of LLO.
 
L. monocytogenes
 
 strain LLO L461T is not defective in 
cell-to-cell spread
 
LLO plays an essential role in the escape of 
 
L. monocytogenes
 
from both the primary phagosome and the secondary double
membrane–bound vesicle formed during cell-to-cell spread
(Tilney and Portnoy, 1989; Gedde et al., 2000). The results
described above did not directly address whether the LLO
L461T mutation affects bacterial cell-to-cell spread. We ex-
amined the ability of bacteria to spread from cell to cell by
measuring the diameter of plaques formed in L2 monolayers
after 3 d in the presence of different concentrations of gen-
tamicin. Plaque diameter is a measure of a bacterium’s ability
to grow, move through the host cell cytosol, enter an adja-
cent cell, and escape from the secondary vesicle formed in the
adjacent cell. At low gentamicin concentrations, the LLO
L461T strain’s plaque was equal in diameter to the wild type,
whereas at high concentrations the mutant had a severe
plaquing defect (Fig. 5). Thus, the capacity of an LLO
L461T mutant to form plaques was gentamicin dependent.
Two 
 
L. monocytogenes
 
 mutants with slight defects in ei-
ther actin-based motility or escape from the double-mem-
braned vesicle were analyzed as controls. The correspond-
ing reduction in the size of plaques formed by these
mutants was independent of gentamicin concentration.
Also, the merodiploid strain with two copies of LLO
formed plaques identical to wild type at each gentamicin
concentration. Therefore, we concluded that LLO L461T
was fully capable of mediating cell-to-cell spread and es-
cape from the double-membraned vesicle. Additionally,
based on the data shown in Figs. 2, 3, and 5, we con-
cluded that the plaque defect seen at high gentamicin
concentrations reflected bacteriocidal activity of the anti-
biotic on intracellular bacteria that entered cells subse-
quent to LLO-mediated damage to the host cell mem-
brane. Conversely, low concentrations of gentamicin did
not allow the influx of sufficient quantities of the antibi-
otic to negatively affect the bacteria. These conclusions
agree with the results observed for the merodiploid,
which did not permeabilize host membranes to pro-
pidium iodide (Fig. 3) nor form gentamicin-sensitive
plaques.
Figure 4. LLO secreted by intracellular L. monocytogenes. 
[35S]Met-labeled LLO from J774 cells infected for 5 h was
immunoprecipitated and examined using SDS-PAGE. Half of the 
protein was used to perform autoradiography, with a representative 
gel shown, and the other half was used for phosphorimaging. As 
published elsewhere (Moors et al., 1999; Decatur and Portnoy, 
2000), two forms of LLO are observed, a full length 58-kD form and 
a truncated 55-kD form. Quantitation of the phosphorimaged samples 
is displayed on the bottom as pixel volume from full-length and the 
truncated form of LLO together. Quantitation of relative band intensity, 
versus wild type, is normalized for colony-forming units of each 
sample at the end of the 5-h experiment. The error measurement 
represents SD of the mean from three experiments.
Figure 5. Cell-to-cell spread of L. 
monocytogenes in different 
concentrations of gentamicin. The 
diameter of bacterial plaques formed 
within L2 cell monolayers over 3 d was 
measured and expressed as a percentage 
of the diameter of wild-type plaques. ActA 
GGG is an L. monocytogenes strain with 
decreased actin-based motility. plcA is 
an L. monocytogenes strain with an 
in-frame deletion in the gene encoding the 
bacterial phosphatidylinositol–specific 
phospholipase C, which leads to a 
reduced ability to escape from the
phagosome. Diploid is a strain containing 
two copies of the gene coding for LLO.
Error bars represent the SD of the mean 
from a minimum of three experiments. 
Representative wells are shown on the 
right.
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Discussion
The pore-forming protein LLO is a primary determinant of L.
monocytogenes pathogenesis that has a pronounced acid pH
optimum and acts in an acidic vacuolar compartment to me-
diate escape of the bacterium into the host cytosol. In this
study, we have examined the role of the acidic pH optimum
in the pathogenesis of L. monocytogenes infection. By swap-
ping residues with the less pH-sensitive ortholog PFO, we
identified an LLO mutant, L461T, that was 10-fold more ac-
tive at a neutral pH than wild-type LLO. L. monocytogenes
synthesizing LLO L461T were 100-fold less virulent in mice
than bacteria secreting the wild-type LLO, indicating that the
acid pH optimum of LLO plays an important role during in-
fection. Tissue culture assays revealed that bacteria synthesiz-
ing LLO L461T were not defective in the extent or pH of pha-
gosomal escape, cell-to-cell spread, or in escape from the
double-membraned vesicle formed during cell-to-cell spread.
However, bacteria synthesizing LLO L461T permeabilized
host plasma membranes, as shown by (a) gentamicin sensitiv-
ity of intracellular bacteria, (b) release of LDH from host cells,
and (c) staining of DNA within infected cells with a mem-
brane-impermeant dye. Thus, the results of this study strongly
suggest that the acidic pH optimum of LLO is necessary to
avoid damage to infected host cells.
LLO is unique among the CDCs in that its activity is nor-
mally repressed at a neutral pH. The biochemical basis of
the LLO pH optimum is not understood; it could reflect pH
sensitivity in membrane binding, oligomerization, and/or
pore formation. It was surprising that a single amino acid
change, from leucine to threonine, could profoundly in-
crease the hemolytic activity of LLO at a neutral pH. Nei-
ther leucine nor threonine alone contains properties that
would suggest sensitivity to pH. The alteration from a non-
polar leucine to a polar threonine residue offers the potential
of an additional hydrogen bond and a reduction in hydro-
phobicity, but in the absence of a detailed structure for
LLO, it is difficult to determine the influence of these
changes. However, if we assume a general structural similar-
ity to PFO, because LLO and PFO are 42% identical (Ross-
john et al., 1997), then the L461T mutation is located on an
outer loop of the fourth domain. Domain 4 has been impli-
cated in both membrane binding and oligomerization (Na-
kamura et al., 1995; Bayley, 1997). Therefore, it is possible
that the mutation may alter interactions with the target lipid
bilayer or with other monomers in a pH-sensitive fashion.
Also, there is evidence that domain 4 must undergo signifi-
cant movement relative to the other domains when the
monomer enters the lipid bilayer (Gilbert et al., 1999). In
particular, the transmembrane hairpins of domain 3 have
been proposed to pack with domain 4 when inserted in the
membrane. The mutation of leucine 461 to threonine might
affect intramolecular interactions in a manner that would
make the cytolysin less sensitive to pH. The precise effect of
the L461T mutation awaits additional biochemical analysis.
There are numerous examples of pathogens exploiting
acidified compartments via pH-dependent proteins, includ-
ing the viral hemagglutinins (Hernandez et al., 1996) and
bacterial and protozoal toxins (Ley et al., 1990; Falnes and
Sandvig, 2000). These precedents led us to hypothesize that
the acidic optimum of LLO provides a mechanism to coor-
dinate optimal pore-forming activity with maturation of the
phagosome to allow efficient phagosomal escape, and any
perturbation of this coordination would result in less effi-
cient escape. Consistent with this hypothesis, a number of
studies have shown that bafilomycin A1, a pharmacological
inhibitor of phagosomal acidification, blocks the escape of L.
monocytogenes from a phagosome (Conte et al., 1996; Beau-
regard et al., 1997). Therefore, it was surprising to find that
the bacteria synthesizing a mutant LLO more active at a
neutral pH escaped from the phagosome with a similar effi-
ciency and at the same pH as wild-type bacteria. These data
suggest that though acidification of the phagosome is impor-
tant for bacterial escape, the pH sensitivity is not manifested
through LLO activity. Given that bafilomycin A1 blocks
maturation of endosomes (van Weert et al., 1995), these
data suggest that a pH-dependent process other than LLO
activity is involved in vacuolar perforation and escape.
Although the precise mechanism of vacuolar escape is not
understood, there is recent evidence that CDCs, including
LLO, may act as mediators of protein delivery to the host
cytosol, similarly to the gram negative type III secretion sys-
tem (Sibelius et al., 1996; Wadsworth and Goldfine, 1999;
Madden et al., 2001). If indeed LLO acts to mediate cytoso-
lic delivery from the phagosome, it is possible that the acid
dependence is required for activation of some other pH-sen-
sitive bacterial effector. At least one other L. monocytogenes
virulence factor, a broad-range phospholipase C, is released
upon vacuolar acidification (Marquis and Hager, 2000), so
it is possible that LLO simply needs to form a pore to allow
the transfer of the pH-sensitive effector to the cytosol to me-
diate vesicular escape. Another possibility is that a host fac-
tor involved in the escape process requires acidification to be
activated or localized to the phagosome.
The most striking phenotype exhibited by L. monocytogenes
expressing LLO L461T was the increased damage inflicted on
the host cells’ membranes. The simplest explanation for this
observation is that LLO L461T is active within the neutral
pH of the cytosol and passes a threshold at which the number
of pores formed by the toxin overwhelms the host cell’s mem-
brane repair mechanisms (Walev et al., 2001). Alternately, it
is possible that the mutation may lead to host cell damage
through an unknown mechanism. However, our data clearly
indicate that bacteria synthesizing LLO L461T permeabilize
J774 host cells as early as 5 h after infection, whereas perme-
abilization by the wild type requires 8 h. It has been estimated
that one bacterium secretes one LLO molecule per minute
(Villanueva et al., 1995). Based on this rate and the doubling
times for each strain, we calculated that at the time of perme-
abilization, the host cell is confronted with the production of
35 LLO L461T molecules per minute, enough monomers
to assemble approximately one pore. In contrast, the wild-
type bacteria are producing 420 LLO per minute when they
permeabilize the host cell after 8 h of growth. These calcula-
tions indicate that bacteria synthesizing LLO L461T perme-
abilized the host cell with about one twelfth the production
rate of wild type. This difference indicates that the unique
acidic activity optimum of wild-type LLO enables L. monocy-
togenes to produce at least 10 times the number of progeny per
infected host cell before significant host damage occurs.
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Many factors contribute to the host cell’s ability to deal
with the presence of LLO within the cytosol. In light of
studies suggesting that host cytosolic proteases cleave LLO
(Villanueva et al., 1995; Decatur and Portnoy, 2000), an al-
ternate explanation for the greater toxicity of LLO L461T is
that it is less susceptible to proteolytic degradation. We ob-
served an approximately twofold higher concentration of
LLO L461T in the cytosol of J774 host cells, yet found that
equal quantities of LLO were produced in vitro. Perhaps the
greater concentration of LLO L461T reflected the fact that
the cytolysin entered membranes more readily in the neutral
pH of the cytosol where it was protected from proteolytic
degradation, as has been shown for other CDCs (Nakamura
et al., 1995). Regardless of the precise mechanism leading to
the greater concentration of intracellular LLO L461T, we
found that intracellular concentrations of LLO did not cor-
relate with membrane permeabilization. A merodiploid
LLO strain producing twice as much LLO was no more cy-
totoxic than the wild type, suggesting that a twofold increase
in LLO concentration alone does not affect membrane dam-
age under these conditions. However, a merodiploid strain
synthesizing both the LLO L461T and the wild-type LLO
acted similarly to the LLO L461T strain in the plaquing as-
say, producing gentamicin-sensitive plaques (unpublished
data), suggesting that the mutant’s cytotoxic phenotype is
dominant over the wild type. These data suggest that the in-
creased host membrane damage was due to the 10-fold
greater activity of LLO L461T at a neutral pH and not sim-
ply intracellular LLO concentration.
The results of this study showed that L. monocytogenes ex-
pressing LLO L461T was 100-fold less virulent than the
wild type. We hypothesize that the increased damage to the
plasma membrane observed in tissue culture correlates with
the defect in virulence in vivo. Additionally, we found that
the LLO L461T grew less well in immunologically naive
mice as early as 12 h after infection (unpublished data).
Thus, the adaptive immune response probably plays little
role in mediating the defect of the mutant bacteria. Instead,
the defect is more likely to reflect the action of the innate
immune response or a more basic defect in the bacterial life
cycle in vivo. We can envision a number of scenarios that
may lead to the mutant’s virulence defect. One possibility is
that a damaged cell no longer provides the advantages of an
intracellular lifestyle, whether it is caused by the loss of ac-
cess to nutrients, reduced actin-based motility, a loss of pro-
tection from humoral defenses, or another unknown mecha-
nism. However, because the mutant grows and spreads
normally at low gentamicin concentrations, a more likely
possibility is that the mutant elicits a greater inflammatory
response at the foci of infections due to greater cytotoxicity,
thereby recruiting a greater number of leukocytes to the fo-
cus of infection. The hemolytic activity of LLO causes the
production of inflammatory cytokines, leading to activation
and chemotaxis of neutrophils and monocytes, which are
largely responsible for containing the bacteria (Unanue,
1997; Kayal et al., 1999; Sibelius et al., 1999).
The results of this study support the concept that L.
monocytogenes has evolved to minimize harm to its host cell.
To achieve maximal virulence, the bacteria must maintain
an equilibrium between producing a molecule that is cy-
tolytic enough to mediate escape from the vesicle, yet not
overly toxic to infected host cells. We hypothesize that L.
monocytogenes has acquired a pathoadaptive mutation (So-
kurenko et al., 1999) converting the primordial residue 461
to a leucine. This mutation is found solely in pathogenic
Listeria and converts LLO from a toxin appropriate for an
extracellular pathogen to that of an intracellular pathogen.
Thus, LLO is highly active where it needs to be, in the acidic
phagosome, yet relatively inactive in the neutral pH of the
cytosol. Together with previously published data that LLO
contains a PEST-like sequence that also reduces its toxicity
(Decatur and Portnoy, 2000), our data imply that L. mono-
cytogenes has evolved multiple failsafe mechanisms to regu-
late the activity of LLO, a molecule that has the potential to
destroy its intracellular niche. Indeed, it has been hypothe-
sized that the host cell uses these same acidic properties of
the endocytic pathway to compartmentalize the activity of
its own potentially hazardous lysosomal enzymes (Mellman
et al., 1986).
Materials and methods
Bacterial strains, growth conditions, and reagents
The wild-type L. monocytogenes strain used for these studies was 10403S. L.
monocytogenes strains with deletions of actA were constructed by allelic ex-
change as described previously (Skoble et al., 2000). The L. monocytogenes
strain with an in-frame deletion of PI-PLC (plcA, or DP-L1552) and strain
ActA GGG (DP-L4032) were previously described (Camilli et al., 1993;
Skoble et al., 2001). The merodiploid hly strain (DP-L4076) will be pub-
lished in a subsequent manuscript (unpublished data). E. coli strains DH5
(GIBCO BRL) or XL-1 Blue (Stratagene) were used for cloning. E. coli strains
BL21(DE3) or BL21(DE3)PlysS (Stratagene) were used for expression of pro-
teins from pET vectors.
L. monocytogenes was grown in 3 ml brain heart infusion broth (BHI;
Becton Dickinson) slanted without agitation in 15 ml conical tubes at 30	C
overnight, unless otherwise noted. All E. coli strains were grown in Luria-
Bertani broth (LB; Becton Dickinson) at 37	C shaking, unless otherwise
noted. All tissue culture cells were grown in DME (GIBCO BRL), contain-
ing 7.5% heat-deactivated FBS (Hy-Clone) and 2 mM glutamine (DME;
GIBCO BRL), at 37	C and 5% CO2, unless otherwise noted. All chemicals
were purchased from Sigma-Aldrich, unless otherwise noted.
Sequences
The GenBank/EMBL/DDBJ accession nos. for the proteins examined in this
study are the following: LLO, M29030; PFO, M36704; ivanolysin O,
X60461; seeligeriolysin O, X60462; streptolysin O, M18638; pneumo-
lysin, X52474; cereolysin, D21270; alveolysin, M62709; suilysin, Z36907;
and pyolysin, U84782.
Cloning
Construction of the LLO expression vector. DNA and protein analysis was
performed using MacVector software (Genetics Computer Group). The re-
gion of hly coding for mature LLO was amplified by PCR, with the primers
and templates described in Table II, using Vent polymerase (New England
Biolabs, Inc.) to introduce a six histidine tag. The amplified fragment was
then cut with restriction enzymes and ligated into pET29b (Novagen). This
plasmid and all other plasmids were initially cloned in E. coli strain XL-1
Blue and then transferred into E. coli expression strain BL21(DE3), unless
otherwise noted, to yield strain DP-3570.
Construction of the PFO expression vector. Mature PFO was amplified by
PCR from p1868 (Jones and Portnoy, 1994a), a plasmid carrying the cod-
ing sequence for mature PFO from Clostridium perfringens, using the prim-
ers, templates, and restriction sites described in Table II. This fragment was
ligated into pET28a (Novagen) and later expressed with BL21(DE3)PlysS,
strain DP-4167.
Construction of the domain chimeras, subdomain chimeras, and single
amino acid mutation expression vectors. The fourth domain of LLO was re-
placed by PFO domain 4 using splicing by overlap extension PCR (Horton
et al., 1990) with the components and restriction sites described in Table
II. The subdomain chimeras and the single amino acid mutations indicated
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in Fig. 1 were constructed by modifying p3570 with the protocol pub-
lished in the Quickchange™ site-directed mutagenesis kit (Stratagene) and
the primers listed in Table II.
Hemolytic activity screening of recombinant proteins
E. coli expression strains were grown overnight in LB containing 30 g/ml
kanamycin (LB-KAN). 400 l of the overnight culture was added to 10 ml
LB-KAN and grown for 1.5 h, and then 1 mM IPTG was added. This culture
was incubated at 30	C, shaking for 3 h. Cultures were pelleted and then re-
suspended in 1 ml storage buffer (140 mM sodium chloride, 4 mM potas-
sium chloride, 10 mM sodium phosphate, 0.5 mM DTT, pH 6.0) with 1 mM
PMSF. The samples were sonicated on ice and cleared by centrifugation.
The quantitative assay was performed in a 96-well V-bottom styrene
plate (Corning Inc.) with either neutral hemolysis buffer (35 mM sodium
phosphate, 125 mM sodium chloride, 0.5 mg/ml BSA, pH 7.4, using acetic
acid) or acidic hemolysis buffer (same as neutral hemolysis buffer but pH
Table II. Oligonucleotides and cloning strategies
Number Sequence 5
→3
 (including enzyme site)a Construct Templateb Cloningc method Pair
3140 GGAATTCCATATGAAGGATGCATCTGCATTCAAT (Nde1) His-LLO, p3570 10403S genomic DNA B 3232
3232 CGGGATCCTTATTAGTGGTGGTGGTGGTGGTGTTCGATTG
GATTATCTAC (BamH1)
His-LLO, p3570 10403S genomic DNA B 3140
3541 GGAATTCCCATGGGAAAGGATATAACAGATAAAAATCA 
(Nco1)
His-PFO, p4167 p1868 B 3542
3542 CGGGATCCTTATTAGTGGTGGTGGTGGTGGTGATTGTAAG
TAATACTAGATCCA (BamH1)
His-PFO, p4167 p1868 B 3541
3543 ACGCGTCGACTTATTAGTGGTGGTGGTGG (Sal1) His-LLO(1-3)PFO4 p1868 S 3578, 3575
3575 GGAATTCCATATGAAGGATGCATCTGCA (Nde1) His-LLO(1-3)PFO4 p3570 S 3543, 3579
3578 ACTATGATCTAAGTTTATTTTTCCATCTGTATAAGC His-LLO(1-3)PFO4 p1868 S 3543
3579 GCTTATACAGATGGAAAAATAAACTTAGATCATAGT His-LLO(1-3)PFO4 p3570 S 3575
3740 GGAGGATACGTTGCTCAATTCGAAGTAGCCTGGGATGAAG
TAAATTATGAT
Chimera 1 p3570 Q 3741
3741 ATCATAATTTACTTCATCCCAGGCTACTTCGAATTGAGCAAC
GTATCCTCC
Chimera 1 p3570 Q 3740
3742 AACATTTCTTGGGATGAAGTATCATATGACAAAGAAGGTAA
CGAAATTGTTCAA
Chimera 2 p3570 Q 3743
3743 TTGAACAATTTCGTTACCTTCTTTGTCATATGATACTTCATCC
CAAGAAATGTT
Chimera 2 p3570 Q 3742
3744 TATGATCCTGAAGGTAACGAAGTATTAACTCATAAAAACTG
GAGCGAAAAC
Chimera 3 p3570 Q 3745
3745 GTTTTCGCTCCAGTTTTTATGAGTTAATACTTCGTTACCTTCA
GGATCATA
Chimera 3 p3570 Q 3744
3746 AACGAAATTGTTCAACATAAAACATGGGATGGAAACAATAA
AAGCAAGCTAGCT
Chimera 4 p3570 Q 3747
3747 AGCTAGCTTGCTTTTATTGTTTCCATCCCATGTTTTATGTTGA
ACAATTTCGTT
Chimera 4 p3570 Q 3746
3748 CATAAAAACTGGAGCGAAAACTATCAAGATAAAACAGCTCA
TTTCACATCGTCCATC
Chimera 5 p3570 Q 3749
3749 GATGGACGATGTGAAATGAGCTGTTTTATCTTGATAGTTTTC
GCTCCAGTTTTTATG
Chimera 5 p3570 Q 3748
3750 AATAAAAGCAAGCTAGCTCATTATTCAACAGTAATCTATTTG
CCTGGTAACGCG
Chimera 6 p3570 Q 3751
3751 CGCGTTACCAGGCAAATAGATTACTGTTGAATAATGAGCTA
GCTTGCTTTTATT
Chimera 6 p3570 Q 3750
3752 GCTCATTTCACATCGTCCATCCCTCTTGAAGCTAACGCGAG
AAATATTAATGTT
Chimera 7 p3570 Q 3753
3753 AACATTAATATTTCTCGCGTTAGCTTCAAGAGGGATGGACG
ATGTGAAATGAGC
Chimera 7 p3570 Q 3752
3754 CCTGGTAACGCGAGAAATATTAGAATAAAAGCAAGAGAAT
GCACTGGTTTAGCTTGG
Chimera 8 p3570 Q 3755
3755 CCAAGCTAAACCAGTGCATTCTCTTGCTTTTATTCTAATATTT
CTCGCGTTACCAGG
Chimera 8 p3570 Q 3754
3756 TGGGAATGGTGGAGAGATGTAATTGATGACCGG Chimera 9 p3570 Q 3757
3757 CCGGTCATCAATTACATCTCTCCACCATTCCCA Chimera 9 p3570 Q 3756
3758 GGGAATGGTGGAGAACGGTAATTAGTGAATATGATGTTCC
ACTTGTGAAAAATAGAAAT
Chimera 10 p3570 Q 3759
3759 ATTTCTATTTTTCACAAGTGGAACATCATATTCACTAATTACC
GTTCTCCACCATTCCC
Chimera 10 p3570 Q 3758
3760 GACCGGAACTTACCACTTACAAATAATATAAATATCTCCATC
TGGGGC
Chimera 11 p3570 Q 3761
3761 GCCCCAGATGGAGATATTTATATTATTTGTAAGTGGTAAGTT
CCGGTC
Chimera 11 p3570 Q 3760
3580 AGATCCAGGGTATAAAGTGGTGCCCCAGATGGAGAT Chimera 12 p3570 Q 3581
3581 ATCTCCATCTGGGGCACCACTTTATACCCTGGATCT Chimera 12 p3570 Q 3580
3799 GAAAACAATAAAAGCAAGACAGCTCATTTCACATCGTCC His-L461T and DP-L4017 10403S genomic DNA QS 3800
3800 GGACGATGTGAAATGAGCTGTCTTGCTTTTATTGTTTTC His-L461T and DP-L4017 10403S genomic DNA QS 3799
3931 TTTCTGCAGAGAAACACGCGGATGAAATCGATA (Pst1) DP-L4017 10403S genomic DNA S 3800, 3932
3932 AAAAGAGCTCTCTGGAATTGAGGATGATTTCTTT (Sac1) DP-L4017 10403S genomic DNA S 3799, 3931
aCustom oligonucleotides were purchased from Operon Technologies and all restriction enzymes were from New England Biolabs, Inc.
bPlasmid DNA was purified with a Qiagen plasmid midi kit and L. monocytogenes genomic DNA was isolated using a FastDNA® kit from Bio101.
cB, basic PCR followed by plasmid ligation; S, splicing by overlap extension PCR and then plasmid ligation (Horton et al., 1990); Q, QuickchangeTM PCR (Stratagene).
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5.5). Samples were serially diluted, and then 0.5% sheep red blood cells
(HemoStat Laboratories) were added to each well. The plate was incu-
bated, shaking at 37	C, and then pelleted in the V-bottom. Supernatant
was transferred from the V-bottom plate into equivalent locations in a flex-
ible polyvinyl chloride flat bottom 96-well plate (Becton Dickinson), and
the absorbance at 450 nm for each well was measured (Spectramax340)
and analyzed with SoftMax Pro v1.2 software (Molecular Devices Corp.).
Hemolytic units were defined as the dilution of the sample at which 50%
of the sheep red blood cells had been lysed.
Overexpression and purification of 6 his–tagged LLO proteins 
and 6 his–tagged PFO from E. coli
Recombinant strains were grown, shaking at 37	C, in LB-KAN to stationary
phase. 20 ml of this culture was inoculated into 1 liter of LB-KAN and incu-
bated, shaking at 30	C, for 90 min. Expression was induced by the addition
of 1 mM IPTG, and the culture was incubated, shaking at 30	C, for 6 h. The
bacterial pellet was harvested by centrifugation, resuspended in 40 ml cold
lysis buffer (50 mM sodium phosphate, pH 8.0, 1 M sodium chloride, 20
mM imidazole, 10 mM 2-mercaptoethanol, 1 mM PMSF), and lysed in a
French pressure cell at 12,000 psi. The lysate was centrifuged for 20 min at
17,000 g. The supernatant was collected and mixed into 5 ml Ni-NTA resin
(QIAGEN) equilibrated in lysis buffer. The slurry was stirred at 4	C for 60
min to bind his-tagged protein to the resin. To remove unbound protein,
the resin was packed into a column and washed with lysis buffer by drop-
wise gravity flow until UV absorbance of the eluate reached baseline, and
then it was washed with wash buffer (lysis buffer, pH 6.0, 10% glycerol,
0.1% Tween 20). Washed resin was removed from the column, resus-
pended in elution buffer (lysis buffer, pH 6.0, and 800 mM imidazole), and
incubated 10 min on ice, after which the supernatant was collected. This
procedure was performed twice, yielding 6 ml eluate. Eluate was dialyzed
in cassettes (Pierce Chemical Co.) within autoclaved storage buffer (lysis
buffer, pH 6.0, with 1 mM EDTA). Both the Bradford method and UV280
absorbance determined protein concentrations. The procedure yielded
25 mg protein per liter starting culture. Aliquots not used immediately
were stored in storage buffer with 50% glycerol at 80	C.
Allelic exchange of LLO L461T
To introduce the LLO L461T mutation onto the 10403S chromosome, a
DNA fragment was produced by splicing by overlap extension PCR, using
the primers, templates, and restriction enzymes in Table II, and then li-
gated into the temperature-sensitive plasmid vector pKSV7. Allelic ex-
change was performed as described previously (Camilli et al., 1993).
Strains were verified initially by detecting the loss of an Nhe1 site in a
chromosomal PCR product containing the mutation.
Animal studies
LD50 by intravenous infection was established as previously described us-
ing BALB/c mice (Portnoy et al., 1988).
Phagosomal escape assay
The percentage of bacteria that had escaped from the phagosome was de-
termined by evaluating the presence of F-actin–coated bacteria within the
macrophage, similar to an experiment previously described (Jones and Port-
noy, 1994a). C57/BL6 BMs in DME, 10% FBS, with or without 0.5 M
bafilomycin A1 (Calbiochem), on a coverslip were infected for 15 min, re-
sulting in a bacterium within 1/10 macrophages. Macrophages were
washed with Ringer’s buffer (5 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 2 mM NaH2PO4, 10 mM Hepes, 10 mM glucose, pH 7.2) and 25
g/ml gentamicin was added. At 120 min after infection, the macrophages
were fixed for 15 min with cytoskeletal fixative (40 mM Hepes, 10 mM
EGTA, 0.5 mM EDTA, 5 mM MgSO4, 33 mM potassium acetate, 0.02% so-
dium azide, 5% polyethylene glycol 400, 4% paraformaldehyde), washed,
permeabilized with PBS, containing 2% goat serum and 0.3% Triton X-100,
and stained with Texas red–phalloidin (Molecular Probes) and DAPI (Mo-
lecular Probes). A total of 50 macrophages harboring bacteria were exam-
ined for each bacterial strain in each of four experiments.
The determination of phagosomal pH was performed essentially as pre-
viously described (Beauregard et al., 1997) with the following modifica-
tions. In brief, fluid-phase fluorescein dextran, molecular weight 10,000
(Molecular Probes), was added to the bacteria-containing media used to
infect macrophages. Phagosomes containing both 10-kD fluorescein dex-
tran and bacteria were photographed every 30 s with a Quantix cooled
charge-couple device camera (Photometrics) through fluorescent micros-
copy using a Nikon TE300 inverted microscope (Nikon), with phase-con-
trast and excitation wavelengths 485 and 440 nm and emission measure-
ment at 520 nm. Images and the 485:440 ratio were collected until
perforation was indicated by loss of dye from the vacuole. The 485:440 ra-
tio measured just before perforation was compared with a standard curve
to establish pH, as described in the published methods.
Cytotoxicity assays
Growth in J774 macrophage-like cells. Intracellular growth of L. monocytog-
enes was performed as previously described (Jones and Portnoy, 1994b).
Flow cytometry. Flow cytometry was performed on cultures of BMØs
from CD-1 mice as previously described (Portnoy et al., 1988). BMØ
were chosen for this assay because infected J774 are difficult to remove
from tissue culture dishes without causing plasma membrane damage,
whereas BMØ lift from the dish when incubated at 4	C. 106 macro-
phages were plated on 60-mm Lab-tek nontissue culture dishes (Fisher
Scientific) overnight in bone marrow macrophage media (DME, 20%
heat-deactivated FBS, 30% L cell supernatant containing CSF-1 in DME,
2 mM glutamine, 1 mM pyruvate, 0.1% 2-mercaptoethanol). Monolayers
were infected with 107 washed bacteria for 30 min resulting in at least
one bacterium per cell. 60 min after infection, 50 g/ml gentamicin was
added. 3 h after infection, the cell monolayer was washed to remove the
gentamicin, and then fresh medium was added to the dish. 7 h after in-
fection, medium from each culture was collected. 4	C PBS was then
added and the dish was stored at 4	C for 30 min. Release of macro-
phages from the dish was monitored by microscopy. The macrophage-
containing PBS was added to the previously removed media and centri-
fuged at 4	C. The pellet was washed with 4	C PBS, 10% FBS. Cell pellets
were resuspended in PBS (10% FBS) and passed through a 70-m cell
strainer (Becton Dickinson). 1 g propidium iodide (Molecular Probes)
was added to each sample. Samples were analyzed with a flow cytome-
ter (EPICS XL-MCL; Beckman Coulter).
LDH release assay. LDH release assays were performed using the Cyto-
tox 96® nonradioactive cytotoxicity assay (Promega), according to manu-
facturer’s instructions and methods described previously (Decatur and
Portnoy, 2000), with 2  104 J774 cells per well infected to achieve at
least one bacterium per cell. Neutralizing anti-LLO monoclonal antibodies
were supplied by Brian Edelson and Emil Unanue (Washington University
School of Medicine, St. Louis, MO).
Intracellular LLO analysis
Intracellular levels of LLO were studied with previously established meth-
ods (Moors et al., 1999) and the following modifications. In brief, J774
cells were infected with L. monocytogenes strains for 30 min and then
washed, and 50 g/ml gentamicin was added at 60 min. 4 h after infec-
tion, methionine-starved cells were pulsed with [35S]methionine (NEN Life
Science Products) for 1 h. At 5 h, macrophages were lysed, LLO was im-
munoprecipitated, and one half of the sample was subjected to SDS-PAGE
for autoradiography and the other half run for analysis on a Phosphorim-
ager 445 SI (Molecular Dynamics) and analyzed using Imagequant soft-
ware (Molecular Dynamics). Monoclonal anti-LLO antibodies were sup-
plied by Pascale Cossart (Institute Pasteur, Paris, France). The relative
number of bacteria in each assay was established by lysing the infected
J774 on coverslips in dishes processed in tandem with the radiolabeled
dishes. Lysate was subsequently plated on LB-agar plates to determine col-
ony-forming units.
Plaque assay
Plaquing assays within L2 cell monolayers were performed as described
previously (Sun et al., 1990), with modifications to the methods of mea-
surement (Skoble et al., 2000). In brief, L2 cells were grown to confluency
in six-well tissue culture dishes and then infected with bacteria for 1 h.
Subsequently, DME-agar containing gentamicin was added and plaques
were grown for 3 d. Living cells were visualized by adding on day 3 an ad-
ditional DME-agar overlay containing neutral red (GIBCO BRL) and incu-
bating overnight.
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